300110.SZ
Huaren Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 2.80
−2.10%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.1x
Market Cap
CNY 3.31B
MomentumView details →
1D Return
−2.10%
YTD Return
−10.79%
RSI (14)
47.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−12.1x
Market Cap
CNY 3.31B
RSI (14)
47.7
MomentumView details →
1D Return
−2.10%
YTD Return
−10.79%
Similar companies
Latest newsMore news →
Huaren Pharmaceutical reported its first-half 2026 results: revenue of 605 million yuan, down 3.02% year-on-year; net profit attributable to shareholders of 28.5424 million yuan, down 23.55%; non-recurring net profit of 25.4503 million yuan, down 8.09%. The company plans no cash dividend, no bonus shares, and no capital reserve conversion.11d agoHuaren Pharmaceutical appointed Zhang Xinzhong as Vice President.66d ago